{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:20:21Z","timestamp":1740136821279,"version":"3.37.3"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1124\/jpet.122.001444","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T20:30:17Z","timestamp":1673555417000},"page":"439-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ocular Administration of Palonosetron in the Prevention of Cisplatin-Induced Nausea and Vomiting"],"prefix":"10.1016","volume":"384","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3504-122X","authenticated-orcid":false,"given":"Jouko","family":"Levijoki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lasse","family":"Saloranta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Tuunainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janne","family":"Kaskinoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sari","family":"Pappinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Nourry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Betat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Maurin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarit","family":"Pakarinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sari","family":"H\u00e4kkinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Tervapuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hertta","family":"Pihlasvaara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Drieu La Rochelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heikki","family":"Joensuu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.122.001444_bib1","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/j.1476-5381.2011.01669.x","article-title":"Predicting the emetic liability of novel chemical entities: a comparative study","volume":"165","author":"du Sert","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001444_bib0828950","first-page":"33","article-title":"Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purpose","volume":"L 276","author":"European","year":"2010","journal-title":"Official Journal of the European Union"},{"key":"10.1124\/jpet.122.001444_bib2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/annonc\/mdq457","article-title":"Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation","volume":"22","author":"Giralt","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1124\/jpet.122.001444_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2354.2012.01353.x","article-title":"Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis","volume":"22","author":"Jin","year":"2013","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1124\/jpet.122.001444_bib4","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1007\/s00221-014-3961-6","article-title":"Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration","volume":"232","author":"Kenward","year":"2014","journal-title":"Exp Brain Res"},{"key":"10.1124\/jpet.122.001444_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1634\/theoncologist.2010-0198","article-title":"A systematic review and meta-analysis of intravenous palonosetron in the prevention of chemotherapy-induced nausea and vomiting in adults","volume":"16","author":"Likun","year":"2011","journal-title":"Oncologist"},{"key":"10.1124\/jpet.122.001444_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/bmt.2009.114","article-title":"Palonosetron and dexamethasone for prevention of nausea and vomiting in patients receiving high-dose chemotherapy with auto-SCT","volume":"45","author":"Musso","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1124\/jpet.122.001444_bib7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00520-016-3445-2","article-title":"A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation","volume":"25","author":"Nakagaki","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1124\/jpet.122.001444_bib8","unstructured":"National Comprehensive Cancer Network (2022) Antiemesis (Version 2.2022)."},{"year":"2011","series-title":"Guide for the Care and Use of Laboratory Animals","key":"10.1124\/jpet.122.001444_bib88"},{"key":"10.1124\/jpet.122.001444_bib9","article-title":"Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis","volume":"11","author":"Piechotta","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/jpet.122.001444_bib10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1124\/jpet.110.166181","article-title":"The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits substance P-mediated responses in vitro and in vivo","volume":"335","author":"Rojas","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001444_bib11","first-page":"713","article-title":"Update on the management of chemotherapy-induced nausea and vomiting - focus on palonosetron","volume":"11","author":"Zhou","year":"2015","journal-title":"Ther Clin Risk Manag"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524004130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524004130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.122.001444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:28:03Z","timestamp":1739971683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524004130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0022356524004130"],"URL":"https:\/\/doi.org\/10.1124\/jpet.122.001444","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular Administration of Palonosetron in the Prevention of Cisplatin-Induced Nausea and Vomiting","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.122.001444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}